Applications for the 2027 Open Academy x ERDERA Schools offer patient advocates and early-career researchers the opportunity to strengthen their knowledge and participation in rare disease research.

The 2027 Open Academy x ERDERA Schools is now open for application

Today 1 september 2026 applications have opened for patient advocates and early-career researchers wishing to join the 2027 Open Academy x ERDERA Schools and build the skills needed to contribute meaningfully to rare disease research. Organised by EURORDIS–Rare Diseases Europe through its Open Academy and supported by ERDERA, the European Rare Diseases Research Alliance, the Schools combine online learning with intensive face-to-face training. Participants follow sessions tailored to their chosen track while also learning together through activities designed to strengthen collaboration between patient advocates and researchers.

The Medicines Research & Development School focuses on the pathway from research to medicines, helping participants understand areas such as clinical development, ethics, regulatory processes and patient engagement. The Scientific Innovation & Translational Research School explores how scientific discoveries can be translated into impact for people living with a rare disease.

Open Academy training aims to give participants the knowledge, skills and confidence to contribute to research as informed partners. Graduates also join an international alumni network offering continued access to peer exchange, resources and further learning opportunities.

Prepare to apply

The face-to-face component is planned to take place in Barcelona in June 2027, with final dates to be announced. Prospective applicants can review the programmes and find the latest application information on the Open Academy x ERDERA Schools webpage.

News & Updates

You might also be interested in

September 16 @ 11:00 am - 12:30 pm
A webinar offering practical guidance on how to pitch to investors, aimed at researchers, clinicians, academics and SMEs working on rare disease projects.
This free online session will highlight patient and research perspectives, innovative clinical study methods, and emerging regulatory approaches
September 30 @ 1:00 pm - 2:00 pm
This ERDERA webinar will provide an overview of the regulatory and ethical requirements for advanced therapy medicinal product (ATMP) research, with a particular focus on genome editing and paediatric studies in rare diseases.
October 21 @ 2:30 pm - 5:30 pm
A special anniversary event showcasing how innovation, collaboration and novel trial methodologies are advancing rare disease research.